Akzo Nobel Management
Management criteria checks 2/4
Akzo Nobel's CEO is Greg Poux-Guillaume, appointed in Nov 2022, has a tenure of 2.08 years. total yearly compensation is €4.93M, comprised of 24.8% salary and 75.2% bonuses, including company stock and options. directly owns 0.004% of the company’s shares, worth €398.62K. The average tenure of the management team and the board of directors is 4.7 years and 2.7 years respectively.
Key information
Greg Poux-Guillaume
Chief executive officer
€4.9m
Total compensation
CEO salary percentage | 24.8% |
CEO tenure | 2.1yrs |
CEO ownership | 0.004% |
Management average tenure | 4.7yrs |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | €565m |
Jun 30 2024 | n/a | n/a | €592m |
Mar 31 2024 | n/a | n/a | €534m |
Dec 31 2023 | €5m | €1m | €447m |
Sep 30 2023 | n/a | n/a | €411m |
Jun 30 2023 | n/a | n/a | €309m |
Mar 31 2023 | n/a | n/a | €303m |
Dec 31 2022 | €2m | €204k | €362m |
Compensation vs Market: Greg's total compensation ($USD5.15M) is about average for companies of similar size in the Austrian market ($USD4.36M).
Compensation vs Earnings: Greg's compensation has increased by more than 20% in the past year.
CEO
Greg Poux-Guillaume (54 yo)
2.1yrs
Tenure
€4,934,990
Compensation
Mr. Grégoire Poux-Guillaume, also known as Greg, was Chairman of the Board at medmix AG since September 20, 2021 and continues to served as its Director since 2024. He had been the Chief Executive Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman of the Management Board | 2.1yrs | €4.93m | 0.0042% € 398.6k | |
CFO & Member of Management Board | 6.9yrs | €2.77m | 0.014% € 1.3m | |
Chief Technology Officer | no data | no data | no data | |
Head Of Investor Relations | no data | no data | no data | |
General Counsel | less than a year | no data | no data | |
Global Head of Communications & Public Affairs and Corporate Director | 9.5yrs | no data | no data | |
Chief Human Resources Officer | 1.4yrs | no data | no data | |
Chief Financial Officer of Specialty Chemicals Business | 6.8yrs | no data | no data | |
CEO of Specialty Chemicals | 6.2yrs | no data | no data | |
Chief Integrated Supply Chain Officer | 3.3yrs | no data | no data | |
Chief Development Officer | less than a year | no data | no data | |
Group Treasurer | 8.9yrs | no data | no data |
4.7yrs
Average Tenure
58yo
Average Age
Experienced Management: AKZO's management team is considered experienced (4.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Supervisory Board Chairman | 1.7yrs | €109.29k | 0.0014% € 128.7k | |
Independent Deputy Chairman of the Supervisory Board | 10.7yrs | €133.00k | 0.0019% € 184.1k | |
Independent Member of the Supervisory Board | 7.1yrs | €112.50k | no data | |
Independent Member of Supervisory Board | 2.7yrs | €107.50k | no data | |
Independent Member of the Supervisory Board | 9.9yrs | €100.00k | no data | |
Member of Supervisory Board | less than a year | no data | no data | |
Member of Supervisory Board | less than a year | no data | no data | |
Member of the Supervisory Board | less than a year | no data | no data | |
Independent Member of Supervisory Board | 2.7yrs | €110.00k | no data |
2.7yrs
Average Tenure
63yo
Average Age
Experienced Board: AKZO's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 10:29 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Akzo Nobel N.V. is covered by 58 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Mutlu Gundogan | ABN AMRO Bank N.V. |
Martin Schnee | AlphaValue |
Colin Isaac | Atlantic Equities LLP |